Pfizer Limited Withdraws Its Application For An Extension Of The Indication For Macugen (Pegaptanib Sodium), Europe
The European Medicines Agency has been formally notified by Pfizer Limited of its decision to withdraw its application for an extension of the therapeutic indication for the centrally authorised medicine Macugen (pegaptanib sodium), 0.3 mg solution for injection...